Dr. Che Colpitts was born and raised in Saskatchewan. She obtained BSc and MSc degrees in biochemistry at the University of Regina, where she became fascinated by viruses and how viruses hijack host cells. Dr. Colpitts obtained her PhD in virology from the University of Alberta in Edmonton, where she trained with Dr. Luis Schang and characterized the mechanisms of novel broad-spectrum antivirals targeting the entry of unrelated viruses. She then moved to the lab of Dr. Thomas Baumert at the University of Strasbourg (France) to focus on hepatitis B and C virus entry and to identify novel antiviral strategies targeting entry of these viruses. Most recently, she has been working with Dr. Greg Towers at University College London (UK) to understand how hepatitis C virus uses a host protein, cyclophilin A, to evade intrinsic cellular antiviral responses. Dr. Colpitts is now an assistant professor in the Department of Biomedical and Molecular Sciences at Queen’s University in Kingston.
Currently recruiting for Fall 2020, please contact if interested!